文献速递眼底病与葡萄膜炎

血管性与无血管性视网膜下高反射物质与阿柏西普治疗应答在年龄相关性黄斑变性中的关联

Association of Vascular Versus Avascular Subretinal Hyperreflective Material With Aflibercept Response in Age-related Macular Degeneration.
PubMed 文献 · Am J Ophthalmol · 2017-06-29

这项前瞻性连续干预性病例系列纳入44例44眼初治新生血管性年龄相关性黄斑变性(nAMD)伴视网膜下高反射物质(SHRM)患者,用OCTA定量分析SHRM内血流信号并分为血管性与无血管性两组,所有眼接受3次每月阿柏西普注射。血管性SHRM在治疗后更易持续存在,并与未能达到黄斑干燥相关,提示其预测抗VEGF治疗应答较低。

要点

  • 44眼中血管性SHRM 21眼(47.7%)、无血管性SHRM 23眼(52.3%)。
  • 3次阿柏西普注射后38眼(86.4%)黄斑干燥,24眼(54.5%)SHRM持续存在。
  • SHRM持续存在者血管性SHRM比例更高(75.0% vs 15.0%,P = .86 × 10-4)。

核心结论

  • nAMD中SHRM可经OCTA定量分析分为血管性与无血管性。
  • 血管性SHRM在治疗后持续存在,并与未能达到黄斑干燥相关,提示其预测抗VEGF治疗应答较低。

研究设计与样本

  • 前瞻性连续干预性病例系列,纳入44例44眼初治nAMD且OCT显示SHRM的患者。
  • 所有患者接受OCTA检查并接受3次每月阿柏西普注射。
  • 用OCTA定量分析SHRM内血流信号,将眼分为血管性SHRM组与无血管性SHRM组。

主要发现

  • 44眼中血管性SHRM 21眼(47.7%),无血管性SHRM 23眼(52.3%)。
  • 基线时血管性SHRM眼较无血管性SHRM眼有更高比例的SHRM所致外界膜(ELM)破坏(P = .015)、经典脉络膜新生血管(CNV)(85.7% vs 26.1%,P = .87 × 10-4)及视网膜内液(P = .008)。
  • 3次阿柏西普注射后38眼(86.4%)黄斑干燥,24眼(54.5%)SHRM持续存在。
  • 与SHRM消退眼相比,SHRM持续存在眼有更高比例的血管性SHRM(75.0% vs 15.0%,P = .86 × 10-4)、经典CNV(P = .032)、无息肉样病灶(P = .020)、SHRM所致ELM破坏(P = .042)及视网膜内液(P = .008)。
  • 负荷注射后黄斑干燥与SHRM消退显著相关(P = .025)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate flow signal within subretinal hyperreflective material (SHRM) using optical coherence tomography angiography (OCTA) and its association with aflibercept treatment responses in treatment-naïve neovascular age-related macular degeneration (nAMD). DESIGN: Prospective consecutive interventional case series. METHODS: Forty-four eyes of 44 patients with treatment-naïve nAMD manifesting SHRM on OCT were studied. All patients underwent OCTA and received 3 monthly aflibercept injections. The intrinsic flow signals within SHRM were quantitatively analyzed using OCTA, and eyes were classified into the vascular and avascular SHRM groups. RESULTS: Of 44 eyes, 21 (47.7%) and 23 (52.3%) showed vascular SHRM and avascular SHRM, respectively. Compared with eyes with avascular SHRM, eyes with vascular SHRM showed higher rates of external limiting membrane (ELM) disruption owing to SHRM (P = .015), classic choroidal neovascularization (CNV) (85.7% vs 26.1%, P = .87 × 10-4), and intraretinal fluid (P = .008) at baseline. After 3 aflibercept injections, 38 eyes (86.4%) showed dry macula despite persistent SHRM in 24 eyes (54.5%). Compared with the eyes with resolved SHRM, those with persistent SHRM showed higher rate of vascular SHRM (75.0% vs 15.0%, P = .86 × 10-4), classic CNV (P = .032), absence of polypoidal lesion (P = .020), ELM disruption owing to SHRM (P = .042), and intraretinal fluid (P = .008). Dry macula after loading injections was significantly associated with SHRM resolution (P = .025). CONCLUSIONS: In nAMD, SHRM can be categorized as vascular and avascular by quantitative OCTA analysis. Vascular SHRM persisted after treatment and was associated with failure to achieve dry macula, suggesting that vascular SHRM is predictive of lower response to anti-VEGF therapy.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Kawashima Y, Hata M, Oishi A, et al. Association of Vascular Versus Avascular Subretinal Hyperreflective Material With Aflibercept Response in Age-related Macular Degeneration. Am J Ophthalmol. 2017. PMID: 28669776. doi:10.1016/j.ajo.2017.06.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。